PhRMA says EU, WTO, others are ‘weakening’ IP

Pharmaceutical industry consortium PhRMA has asked the Office of the US Trade Representative (USTR) to put the European Union, the World Trade Organization (WTO) and the UK on a watch list of trading partners that could “weaken” IP rights.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

PhRMA shames Brazil and Thailand over patent backlogs

6 November 2018 Pharmaceutical Research and Manufacturers of America has identified Brazil and Thailand as two of the worst countries for patent delays, in a submission made to a US government report.

Americas

BIO and PhRMA file petition supporting Illumina

7 March 2017 Two biotech associations have filed a petition asking the US Court of Appeals for the Federal Circuit to clarify rules on whether arguments can be brought at a district court if they have been brought at the US Patent and Trademark Office.

More features

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

Former pharma GC brings in-house perspective to McGuireWoods

Sandoz eyes US biosimilar launch as Regeneron settles

Killing the golden goose of US drug innovation (Part I): Follow the money

Buchalter brings in new partner to head up medtech

Trump’s march-in rights threat: Why pharma is rethinking collaborations

UK gets new IP minister following cabinet reshuffle

Barnes & Thornburg reveals five new IP leaders

PhRMA says EU, WTO, others are ‘weakening’ IP

More on this story

Editor's picks

Editor's picks

More features